Beta Bionics (BBNX) Gross Profit (2024 - 2026)

Beta Bionics has disclosed Gross Profit across 3 years of filings, most recently posting $16.4 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $16.4 million, up 83.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $63.0 million (up 67.3% YoY), and the FY2025 annual result was $55.5 million, up 54.75% from the prior year.
• Gross Profit came in at $16.4 million for Q1 2026 at Beta Bionics, down from $18.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $18.9 million in Q4 2025 to a low of $7.2 million in Q1 2024.
• The 3-year median for Gross Profit is $11.7 million (2024), against an average of $12.0 million.
• Across the five-year window, Gross Profit rose 24.58% in 2025 and soared 83.22% in 2026, its largest moves.
• Beta Bionics' Gross Profit stood at $11.7 million in 2024, then surged by 62.07% to $18.9 million in 2025, then decreased by 13.23% to $16.4 million in 2026.
• The last three Gross Profit figures came in at $16.4 million (Q1 2026), $18.9 million (Q4 2025), and $15.1 million (Q3 2025), per Business Quant data.